Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic variation of alcohol dehydrogenase type 1C (ADH1C), alcohol consumption, and metabolic cardiovascular risk factors: results from the IMMIDIET study.
Latella MC, Di Castelnuovo A, de Lorgeril M, Arnout J, Cappuccio FP, Krogh V, Siani A, van Dongen M, Donati MB, de Gaetano G, Iacoviello L; European Collaborative Group of the IMMIDIET Project. Latella MC, et al. Among authors: van dongen m. Atherosclerosis. 2009 Nov;207(1):284-90. doi: 10.1016/j.atherosclerosis.2009.04.022. Epub 2009 Apr 24. Atherosclerosis. 2009. PMID: 19447389
Alcohol consumption and n-3 polyunsaturated fatty acids in healthy men and women from 3 European populations.
di Giuseppe R, de Lorgeril M, Salen P, Laporte F, Di Castelnuovo A, Krogh V, Siani A, Arnout J, Cappuccio FP, van Dongen M, Donati MB, de Gaetano G, Iacoviello L; European Collaborative Group of the IMMIDIET Project. di Giuseppe R, et al. Among authors: van dongen m. Am J Clin Nutr. 2009 Jan;89(1):354-62. doi: 10.3945/ajcn.2008.26661. Epub 2008 Dec 3. Am J Clin Nutr. 2009. PMID: 19056552 Free article.
-344C/T Variant in the promoter of the aldosterone synthase gene (CYP11B2) is associated with metabolic syndrome in men.
Russo P, Lauria F, Loguercio M, Barba G, Arnout J, Cappuccio FP, de Lorgeril M, Donati MB, Iacoviello L, Krogh V, van Dongen M, Siani A; European Collaborative Group of the IMMIDIET Project. Russo P, et al. Among authors: van dongen m. Am J Hypertens. 2007 Feb;20(2):218-22. doi: 10.1016/j.amjhyper.2006.07.012. Am J Hypertens. 2007. PMID: 17261471
Prevalence, awareness, treatment and control of hypertension in healthy unrelated male-female pairs of European regions: the dietary habit profile in European communities with different risk of myocardial infarction--the impact of migration as a model of gene-environment interaction project.
Costanzo S, Di Castelnuovo A, Zito F, Krogh V, Siani A, Arnout J, Cappuccio FP, Miller MA, van Dongen M, de Lorgeril M, de Gaetano G, Donati MB, Iacoviello L; European Collaborative Group of the IMMIDIET project. Costanzo S, et al. Among authors: van dongen m. J Hypertens. 2008 Dec;26(12):2303-11. doi: 10.1097/HJH.0b013e328311ce04. J Hypertens. 2008. PMID: 19008709
Folate intake and folate serum levels in men and women from two European populations: The IMMIDIET project.
Pounis G, Di Castelnuovo AF, de Lorgeril M, Krogh V, Siani A, Arnout J, Cappuccio FP, van Dongen M, Zappacosta B, Donati MB, de Gaetano G, Iacoviello L; European Collaborative Group of the IMMIDIET Project. Pounis G, et al. Among authors: van dongen m. Nutrition. 2014 Jul-Aug;30(7-8):822-30. doi: 10.1016/j.nut.2013.11.014. Epub 2013 Dec 5. Nutrition. 2014. PMID: 24984999
Forns index and fatty liver index, but not FIB-4, are associated with indices of glycaemia, pre-diabetes and type 2 diabetes: analysis of The Maastricht Study.
Heyens L, Kenjic H, Dagnelie P, Schalkwijk C, Stehouwer C, Meex S, Kooman J, Bekers O, van Greevenbroek M, Savelberg H, Robaeys G, de Galan B, Koster A, van Dongen M, Eussen S, Koek G. Heyens L, et al. Among authors: van dongen m. BMJ Open Gastroenterol. 2024 Nov 29;11(1):e001466. doi: 10.1136/bmjgast-2024-001466. BMJ Open Gastroenterol. 2024. PMID: 39615896 Free PMC article.
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial.
Nederlof I, Isaeva OI, de Graaf M, Gielen RCAM, Bakker NAM, Rolfes AL, Garner H, Boeckx B, Traets JJH, Mandjes IAM, de Maaker M, van Brussel T, Chelushkin M, Champanhet E, Lopez-Yurda M, van de Vijver K, van den Berg JG, Hofland I, Klioueva N, Mann RM, Loo CE, van Duijnhoven FH, Skinner V, Luykx S, Kerver E, Kalashnikova E, van Dongen MGJ, Sonke GS, Linn SC, Blank CU, de Visser KE, Salgado R, Wessels LFA, Drukker CA, Schumacher TN, Horlings HM, Lambrechts D, Kok M. Nederlof I, et al. Among authors: van dongen mgj. Nat Med. 2024 Nov;30(11):3223-3235. doi: 10.1038/s41591-024-03249-3. Epub 2024 Sep 16. Nat Med. 2024. PMID: 39284953 Free PMC article. Clinical Trial.
202 results